Amazon’s playbook for upending healthcare is getting clearer, and pharmaceutical companies can’t wait for the tech giant to make its move
|01/29/2019||Posted by BusinessMediaguide.Com under General World News||
- Amazon is getting into the healthcare business. Every move has sent pharmacy and wholesaler stocks into a tizzy.
- But it remains to be seen what impact this has on drugmakers.
- We spoke to more than half a dozen top executives at pharmaceutical companies such as Novartis and Eli Lilly about Amazon’s entry into healthcare.
Amazon has the entire $3.5 trillion healthcare industry on edge.
News of the retail behemoth’s acquisition of PillPack, its plans for a joint healthcare venture with JPMorgan and Berkshire Hathaway, and its work supplying hospitals with health equipment have all sent would-be read more >>>